Cost-Effectiveness of Genotypic Antiretroviral Resistance Testing in HIV-Infected Patients with Treatment Failure

BACKGROUND: Genotypic antiretroviral resistance testing (GRT) in HIV infection with drug resistant virus is recommended to optimize antiretroviral therapy, in particular in patients with virological failure. We estimated the clinical effect, cost and cost-effectiveness of using GRT as compared to ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Sendi, Pedram, Günthard, Huldrych F., Simcock, Mathew, Ledergerber, Bruno, Schüpbach, Jörg, Battegay, Manuel
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1769464/
https://www.ncbi.nlm.nih.gov/pubmed/17245449
http://dx.doi.org/10.1371/journal.pone.0000173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1769464/
https://www.ncbi.nlm.nih.gov/pubmed/17245449
http://dx.doi.org/10.1371/journal.pone.0000173

Ejemplares similares